Jean-Claude Cutz
机构: Pathology and Molecular Medicine, McMaster University
每年引用次数
引用次数
引用: 6,549
H-指数: 31
I10-指数 : 49
出版物: 112
MP-16.01: Reduction of the cytosolic Cdk11 protein expression in clear cell renal cell carcinoma
A. Kapoor , L. He , C. Fan , A. Rybak
Urology 70 ( 3) 122
2007
P2.09-08 Clinical Outcomes of Histology Versus Cytology PD-L1 22C3 Antibody Testing in Advanced Non-Small Cell Lung Cancer
Y. Wang , M. Butcher , A. Naqvi , J. Cutz
Journal of Thoracic Oncology 13 ( 10)
2
2018
P1.09-04 Optimization of PD-L1 Testing Specimen Flow in the Greater Hamilton, Ontario Region
R. Juergens , M. Butcher , A. Naqvi , J. Cutz
Journal of Thoracic Oncology 13 ( 10)
2018
P-682 Development of transplantable tumor lines from a variety ofhuman lung cancers via sub-renal capsule grafting
Y. Wang , J. Cutz , J. Guan , J. English
Lung Cancer 49
2005
P1.01-55 Updated Analysis of Outcomes by Histology vs Cytology PD-L1 22C3 Antibody Testing in Advanced Non-Small Cell Lung Cancer
A. Sathiyapalan , Y. Wang , R. Juergens , M. Butcher
Journal of Thoracic Oncology 14 ( 10)
2019
OA 15.01 Lung Cancer Screening: Participant Selection by Risk Model – the Pan-Canadian Study
M. Tammemägi , H. Schmidt , S. Martel , A. Mcwilliams
Journal of Thoracic Oncology 12 ( 11) S1784 -S1785
2017
Individualized patient care: Are we ready to meet the challenges for patients with lung cancer?
P. M. Ellis , R. VanderMeer , J. Cutz , S. Chambers
Journal of Clinical Oncology 28
2010
A Randomized Phase II Trial of Prostate Boost Irradiation With Stereotactic Body Radiotherapy (SBRT) or Conventional Fractionation (CF) External Beam Radiotherapy (EBRT) in Locally Advanced Prostate Cancer: The PBS Trial (NCT03380806)
Naghmeh Isfahanian , Himanshu Lukka , Ian Dayes , Kimmen Quan
Clinical Genitourinary Cancer 18 ( 4)
3
2020
Translation of Knowledge to Practice-Improving Awareness in NSCLC Molecular Testing
Alona Zer , Jean Claude Cutz , Harman Sekhon , David M. Hwang
Journal of Thoracic Oncology 13 ( 7) 1004 -1011
2
2018
A common presentation with a rare cause
J-C. Cutz , J. S. Woods , J. H. Mitchell , T. V. Colby
European Respiratory Journal 30 ( 3) 594 -597
3
2007
Characterization of Proliferating Lesion-Resident Cells During All Stages of Atherosclerotic Growth.
Richard C. Austin , Šárka Lhoták , Gabriel Gyulay , Jean‐Claude Cutz
Journal of the American Heart Association 5 ( 8)
20
2016
The Cost-Effectiveness of 2nd Line Crizotinib in EML4-Alk Rearranged Advanced NSCLC in Ontario
S. Djalalov , D.M. Graham , J. Beca , J.S. Hoch
Value in Health 17 ( 3)
2014
Cost-Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients with Advanced ALK Positive Non-Small Cell Lung Cancer in a Publicly Funded System (Ontario, Canada)
S. Djalalov , J. Beca , J.S. Hoch , M.D. Krahn
Value in Health 16 ( 7)
1
2013
Diagnosing lung cancer in the 21st century: are we ready to meet the challenge of individualized care?
R. VanderMeer , S. Chambers , A. Van Dam , J.C. Cutz
Current Oncology 22 ( 4) 272 -278
7
2015
Improving molecular testing and personalized medicine in non-small-cell lung cancer in Ontario.
M.S. Tsao , N.B. Leighl , C. Lim , H.S. Sekhon
Current Oncology 24 ( 2) 103 -110
12
2017
Cost-Effectiveness Of Eml4-Alk Fusion Testing In Combination With Crizotinib Treatment For Patients With Advanced Non-Small Cell Lung Cancer Living In Ontario
S. Djalalov , J.S. Hoch , J. Beca , M. Krahn
Value in Health 16 ( 3)
1
2013
Potential use for sulfasalazine in lung cancer therapy
Peter W Gout , Jun Guan , Yuwei Wang , Hui Xue
Cancer Research 64 887 -887
1
2004
Crizotinib inhibition of ROS1-positive tumours in advanced non-small-cell lung cancer: a Canadian perspective
D. G. Bebb , J. Agulnik , R. Albadine , S. Banerji
Current Oncology 26 ( 4) 551 -557
2
2019
IQGAP2 Displays Tumor Suppression Functions
Jean-Claude Cutz , Anil Kapoor , Damu Tang , Hao Peng
Journal of Analytical Oncology 4 ( 2) 86 -93
6
2015
Phase I study of oncolytic virus (OV) MG1 maraba/MAGE-A3 (MG1MA3), with and without transgenic MAGE-A3 adenovirus vaccine (AdMA3) in incurable advanced/metastatic MAGE-A3-expressing solid tumours: CCTG IND.214.
Derek J. Jonker , Sebastien J. Hotte , Albiruni Ryan Abdul Razak , Daniel John Renouf
Journal of Clinical Oncology 35
5
2017